Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Dosing of Nicotine Replacement for Smoking Cessation
NCT03000387Phase 4Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jan 2018
- Primary completion
- Feb 2023
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nicotine patch in Tobacco Use Disorder (TUD) (3 arms), sponsored by Center for Addiction and Mental Health. Primary endpoint: Short term continuous abstinence. Started Jan 2018; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03000387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000387.